Market Place
Sourcing Support
Sorrento Announces Positive Phase 2a Clinical Trial Results for Resiniferatoxin
07 Sep 2023 //
GLOBENEWSWIRE
Sorrento Completes Enrollment of Phase 2 Clinical Trial of Resiniferatoxin
26 Sep 2022 //
GLOBENEWSWIRE
FDA Clears Sorrento Ph 2 Trial Of Non-Opioid Product Candidate Resiniferatoxin
06 Jul 2021 //
GLOBENEWSWIRE
Sorrento announces positive results of Epidural Resiniferatoxin injection
23 Sep 2020 //
PHARMABIZ
Sorrento Therapeutics Releases Positive Results of Resiniferatoxin (RTX) Trial
22 Sep 2020 //
GLOBENEWSWIRE
Sorrento to Present Late Breaking +ve Clinical Trial Data for Resiniferatoxin
27 Jan 2020 //
GLOBENEWSWIRE
Sorrento Therapeutics Closes Acquisition of Scilex
08 Nov 2016 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.